Your browser doesn't support javascript.
loading
Impact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.
Roy, Shumita; Benedict, Ralph H B; Drake, Allison S; Weinstock-Guttman, Bianca.
Affiliation
  • Roy S; Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York (SUNY), Buffalo, NY, USA.
  • Benedict RH; Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York (SUNY), Buffalo, NY, USA. benedict@buffalo.edu.
  • Drake AS; Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York (SUNY), Buffalo, NY, USA.
  • Weinstock-Guttman B; Department of Neurology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York (SUNY), Buffalo, NY, USA.
CNS Drugs ; 30(3): 209-25, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26884145

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholinesterase Inhibitors / Cognitive Dysfunction / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cholinesterase Inhibitors / Cognitive Dysfunction / Multiple Sclerosis Type of study: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: CNS Drugs Journal subject: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: